NASDAQ · Financial Statements
Citius Oncology, Inc. (CTOR) Financial Statements
$0.84
NASDAQ: CTOR
Market Cap $78.09M
Overview Financials Dividend Citius Oncology, Inc. most recently reported annual revenue of $0, net profit of $-25.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2022 2023 2024 2025 Revenue $0 $0 $0 $0 Operating Profit $-10.0M $-12.0M $-21.0M $-24.0M Net Profit $-11.0M $-13.0M $-21.0M $-25.0M EPS $-0.08 $-0.19 $-0.30 $-0.34 Op Margin — — — —
Balance Sheet (USD)
Metric 2022 2023 2024 2025 Total Assets $43.0M $48.0M $84.0M $101.0M Total Liabilities $6.0M $22.0M $38.0M $56.0M Cash $0 $0 $0 $4.0M Borrowings $0 $0 $4.0M $4.0M
Cash Flow (USD)
Metric 2022 2023 2024 2025 Operating Cash Flow $0 $-1.0M $0 $-5.0M Investing Cash Flow $-67.0M $-1.0M $-5.0M $-6.0M Financing Cash Flow $0 $2.0M $1.0M $0 Net Cash Flow $0 $0 $0 $4.0M Free Cash Flow $0 $-1.0M $0 $-5.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.05 EV / EBITDA -1.90 FCF Yield -22.31% Quick Ratio 0.34 Interest Coverage -86.40 Return 1Y -56.84% Return 3Y -93.70% Return 5Y —
Screens featuring this stock